aTyr Pharma | LIFE - Operating Profit


aTyr Pharma reported $24.47M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Ardelyx USD 5.1M 431K Dec/2025
aTyr Pharma USD 24.47M 51.21M Dec/2025
Biogen USD 659.6M 192.2M Sep/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD 56.04M 63.93M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Curis USD -7.88M 4.63M Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Novartis USD 4.06B 437M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Xoma USD -15.64M 5.56M Sep/2024